nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—TLR7—decidua—uterine cancer	0.0174	0.241	CbGeAlD
Hydroxychloroquine—TLR7—uterus—uterine cancer	0.0152	0.211	CbGeAlD
Hydroxychloroquine—TLR7—female reproductive system—uterine cancer	0.0137	0.189	CbGeAlD
Hydroxychloroquine—TLR7—vagina—uterine cancer	0.0124	0.171	CbGeAlD
Hydroxychloroquine—TLR7—lymph node—uterine cancer	0.00799	0.111	CbGeAlD
Hydroxychloroquine—TLR9—PI3K Cascade—STK11—uterine cancer	0.00506	0.0345	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—STK11—uterine cancer	0.00423	0.0289	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—STK11—uterine cancer	0.00411	0.0281	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—STK11—uterine cancer	0.00408	0.0278	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—STK11—uterine cancer	0.00397	0.0271	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—STK11—uterine cancer	0.00397	0.0271	CbGpPWpGaD
Hydroxychloroquine—TLR9—PI3K Cascade—FGFR2—uterine cancer	0.00395	0.0269	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IGF1R—uterine cancer	0.00355	0.0242	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IGF1R—uterine cancer	0.00346	0.0236	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—FGFR2—uterine cancer	0.0033	0.0225	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—STK11—uterine cancer	0.0033	0.0225	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—FGFR2—uterine cancer	0.00321	0.0219	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—FGFR2—uterine cancer	0.00318	0.0217	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—FGFR2—uterine cancer	0.0031	0.0211	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—FGFR2—uterine cancer	0.0031	0.0211	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—FGFR2—uterine cancer	0.00257	0.0176	CbGpPWpGaD
Hydroxychloroquine—Convulsion—Progesterone—uterine cancer	0.00249	0.00319	CcSEcCtD
Hydroxychloroquine—Scotoma—Epirubicin—uterine cancer	0.00249	0.00318	CcSEcCtD
Hydroxychloroquine—Nystagmus—Doxorubicin—uterine cancer	0.00245	0.00313	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00243	0.00312	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Dactinomycin—uterine cancer	0.00243	0.00311	CcSEcCtD
Hydroxychloroquine—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00241	0.00309	CcSEcCtD
Hydroxychloroquine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.0024	0.00307	CcSEcCtD
Hydroxychloroquine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00238	0.00305	CcSEcCtD
Hydroxychloroquine—Oedema—Progesterone—uterine cancer	0.00235	0.00301	CcSEcCtD
Hydroxychloroquine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.003	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Progesterone—uterine cancer	0.0023	0.00295	CcSEcCtD
Hydroxychloroquine—Scotoma—Doxorubicin—uterine cancer	0.0023	0.00295	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00229	0.00294	CcSEcCtD
Hydroxychloroquine—Skin disorder—Progesterone—uterine cancer	0.00228	0.00292	CcSEcCtD
Hydroxychloroquine—Blood disorder—Epirubicin—uterine cancer	0.00226	0.00289	CcSEcCtD
Hydroxychloroquine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00226	0.00289	CcSEcCtD
Hydroxychloroquine—Anorexia—Progesterone—uterine cancer	0.00224	0.00287	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Dactinomycin—uterine cancer	0.00221	0.00283	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00221	0.00282	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.0022	0.00282	CcSEcCtD
Hydroxychloroquine—CYP2D6—renal system—uterine cancer	0.00219	0.0303	CbGeAlD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—CXCL8—uterine cancer	0.00215	0.0147	CbGpPWpGaD
Hydroxychloroquine—Cardiovascular disorder—Epirubicin—uterine cancer	0.00215	0.00275	CcSEcCtD
Hydroxychloroquine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.00273	CcSEcCtD
Hydroxychloroquine—Blood disorder—Doxorubicin—uterine cancer	0.00209	0.00268	CcSEcCtD
Hydroxychloroquine—Skin discolouration—Epirubicin—uterine cancer	0.00209	0.00268	CcSEcCtD
Hydroxychloroquine—Somnolence—Progesterone—uterine cancer	0.00209	0.00267	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00209	0.00267	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00208	0.00267	CcSEcCtD
Hydroxychloroquine—Bronchospasm—Etoposide—uterine cancer	0.00208	0.00266	CcSEcCtD
Hydroxychloroquine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00207	0.00265	CcSEcCtD
Hydroxychloroquine—Alopecia—Dactinomycin—uterine cancer	0.00207	0.00264	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Progesterone—uterine cancer	0.00204	0.00261	CcSEcCtD
Hydroxychloroquine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00203	0.0026	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00203	0.0026	CcSEcCtD
Hydroxychloroquine—Fatigue—Progesterone—uterine cancer	0.00203	0.00259	CcSEcCtD
Hydroxychloroquine—Pain—Progesterone—uterine cancer	0.00201	0.00257	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Etoposide—uterine cancer	0.00201	0.00257	CcSEcCtD
Hydroxychloroquine—Cardiovascular disorder—Doxorubicin—uterine cancer	0.00199	0.00255	CcSEcCtD
Hydroxychloroquine—Skin discolouration—Doxorubicin—uterine cancer	0.00193	0.00248	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Progesterone—uterine cancer	0.00192	0.00246	CcSEcCtD
Hydroxychloroquine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00242	CcSEcCtD
Hydroxychloroquine—Hepatocellular injury—Epirubicin—uterine cancer	0.00189	0.00242	CcSEcCtD
Hydroxychloroquine—Anaemia—Dactinomycin—uterine cancer	0.00188	0.00241	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00187	0.00239	CcSEcCtD
Hydroxychloroquine—Urticaria—Progesterone—uterine cancer	0.00187	0.00239	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Progesterone—uterine cancer	0.00186	0.00238	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Progesterone—uterine cancer	0.00186	0.00238	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00185	0.00237	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00235	CcSEcCtD
Hydroxychloroquine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00235	CcSEcCtD
Hydroxychloroquine—Leukopenia—Dactinomycin—uterine cancer	0.00182	0.00233	CcSEcCtD
Hydroxychloroquine—Aplastic anaemia—Epirubicin—uterine cancer	0.00177	0.00227	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Etoposide—uterine cancer	0.00176	0.00225	CcSEcCtD
Hydroxychloroquine—CYP2D6—female reproductive system—uterine cancer	0.00175	0.0243	CbGeAlD
Hydroxychloroquine—Hepatocellular injury—Doxorubicin—uterine cancer	0.00175	0.00224	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00174	0.00223	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Progesterone—uterine cancer	0.00173	0.00222	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—CXCL8—uterine cancer	0.0017	0.0116	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.00217	CcSEcCtD
Hydroxychloroquine—Asthenia—Progesterone—uterine cancer	0.00169	0.00216	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00215	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00215	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—CXCL8—uterine cancer	0.00168	0.0114	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Progesterone—uterine cancer	0.00166	0.00213	CcSEcCtD
Hydroxychloroquine—Oedema—Dactinomycin—uterine cancer	0.00166	0.00213	CcSEcCtD
Hydroxychloroquine—Aplastic anaemia—Doxorubicin—uterine cancer	0.00164	0.0021	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Dactinomycin—uterine cancer	0.00163	0.00208	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Progesterone—uterine cancer	0.00161	0.00206	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Etoposide—uterine cancer	0.0016	0.00205	CcSEcCtD
Hydroxychloroquine—CYP2D6—female gonad—uterine cancer	0.0016	0.0221	CbGeAlD
Hydroxychloroquine—Anorexia—Dactinomycin—uterine cancer	0.00158	0.00203	CcSEcCtD
Hydroxychloroquine—Eye disorder—Etoposide—uterine cancer	0.00158	0.00202	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—NRAS—uterine cancer	0.00158	0.0108	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.00201	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Epirubicin—uterine cancer	0.00157	0.00201	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Epirubicin—uterine cancer	0.00156	0.002	CcSEcCtD
Hydroxychloroquine—Dizziness—Progesterone—uterine cancer	0.00155	0.00199	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events—NRAS—uterine cancer	0.00153	0.0105	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00196	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—NRAS—uterine cancer	0.00152	0.0104	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00193	CcSEcCtD
Hydroxychloroquine—Alopecia—Etoposide—uterine cancer	0.0015	0.00191	CcSEcCtD
Hydroxychloroquine—Vomiting—Progesterone—uterine cancer	0.00149	0.00191	CcSEcCtD
Hydroxychloroquine—TLR9—PI3K Cascade—PIK3CA—uterine cancer	0.00149	0.0102	CbGpPWpGaD
Hydroxychloroquine—Rash—Progesterone—uterine cancer	0.00148	0.0019	CcSEcCtD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—NRAS—uterine cancer	0.00148	0.0101	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—NRAS—uterine cancer	0.00148	0.0101	CbGpPWpGaD
Hydroxychloroquine—Dermatitis—Progesterone—uterine cancer	0.00148	0.00189	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—IRF1—uterine cancer	0.00148	0.0101	CbGpPWpGaD
Hydroxychloroquine—Headache—Progesterone—uterine cancer	0.00147	0.00188	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00186	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Epirubicin—uterine cancer	0.00145	0.00186	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Doxorubicin—uterine cancer	0.00145	0.00186	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Doxorubicin—uterine cancer	0.00144	0.00185	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Dactinomycin—uterine cancer	0.00144	0.00185	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Epirubicin—uterine cancer	0.00143	0.00184	CcSEcCtD
Hydroxychloroquine—Fatigue—Dactinomycin—uterine cancer	0.00143	0.00183	CcSEcCtD
Hydroxychloroquine—Pain—Dactinomycin—uterine cancer	0.00142	0.00182	CcSEcCtD
Hydroxychloroquine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.0018	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Epirubicin—uterine cancer	0.0014	0.0018	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Epirubicin—uterine cancer	0.0014	0.0018	CcSEcCtD
Hydroxychloroquine—Nausea—Progesterone—uterine cancer	0.0014	0.00179	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—PIK3CA—uterine cancer	0.00136	0.0093	CbGpPWpGaD
Hydroxychloroquine—Anaemia—Etoposide—uterine cancer	0.00136	0.00174	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00136	0.00174	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—KRAS—uterine cancer	0.00136	0.00926	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00173	CcSEcCtD
Hydroxychloroquine—Affect lability—Epirubicin—uterine cancer	0.00135	0.00173	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00134	0.00172	CcSEcCtD
Hydroxychloroquine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00172	CcSEcCtD
Hydroxychloroquine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00172	CcSEcCtD
Hydroxychloroquine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00171	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Doxorubicin—uterine cancer	0.00133	0.0017	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CXCL8—uterine cancer	0.00133	0.00905	CbGpPWpGaD
Hydroxychloroquine—Vertigo—Etoposide—uterine cancer	0.00132	0.00169	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events—KRAS—uterine cancer	0.00132	0.00901	CbGpPWpGaD
Hydroxychloroquine—Leukopenia—Etoposide—uterine cancer	0.00132	0.00169	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Dactinomycin—uterine cancer	0.00131	0.00168	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Dactinomycin—uterine cancer	0.00131	0.00168	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—KRAS—uterine cancer	0.00131	0.00893	CbGpPWpGaD
Hydroxychloroquine—Cardiac failure—Doxorubicin—uterine cancer	0.0013	0.00166	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Doxorubicin—uterine cancer	0.0013	0.00166	CcSEcCtD
Hydroxychloroquine—Mood swings—Epirubicin—uterine cancer	0.0013	0.00166	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Etoposide—uterine cancer	0.00129	0.00166	CcSEcCtD
Hydroxychloroquine—Ataxia—Epirubicin—uterine cancer	0.00129	0.00165	CcSEcCtD
Hydroxychloroquine—Convulsion—Etoposide—uterine cancer	0.00128	0.00163	CcSEcCtD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—KRAS—uterine cancer	0.00127	0.00869	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—KRAS—uterine cancer	0.00127	0.00869	CbGpPWpGaD
Hydroxychloroquine—Liver function test abnormal—Epirubicin—uterine cancer	0.00127	0.00162	CcSEcCtD
Hydroxychloroquine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00162	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Epirubicin—uterine cancer	0.00125	0.0016	CcSEcCtD
Hydroxychloroquine—Affect lability—Doxorubicin—uterine cancer	0.00125	0.0016	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—PIK3CA—uterine cancer	0.00125	0.00851	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00125	0.00159	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00123	0.00158	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—NRAS—uterine cancer	0.00123	0.00839	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Dactinomycin—uterine cancer	0.00122	0.00157	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events—PIK3CA—uterine cancer	0.00121	0.00828	CbGpPWpGaD
Hydroxychloroquine—Muscular weakness—Epirubicin—uterine cancer	0.00121	0.00155	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—PIK3CA—uterine cancer	0.0012	0.0082	CbGpPWpGaD
Hydroxychloroquine—Mood swings—Doxorubicin—uterine cancer	0.0012	0.00154	CcSEcCtD
Hydroxychloroquine—Ataxia—Doxorubicin—uterine cancer	0.00119	0.00153	CcSEcCtD
Hydroxychloroquine—Asthenia—Dactinomycin—uterine cancer	0.00119	0.00153	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Etoposide—uterine cancer	0.00118	0.00151	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Epirubicin—uterine cancer	0.00117	0.0015	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Doxorubicin—uterine cancer	0.00117	0.0015	CcSEcCtD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—PIK3CA—uterine cancer	0.00117	0.00799	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—PIK3CA—uterine cancer	0.00117	0.00799	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Etoposide—uterine cancer	0.00117	0.00149	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—IRF1—uterine cancer	0.00117	0.00796	CbGpPWpGaD
Hydroxychloroquine—Abdominal pain upper—Doxorubicin—uterine cancer	0.00116	0.00148	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—HRAS—uterine cancer	0.00115	0.00787	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Etoposide—uterine cancer	0.00115	0.00147	CcSEcCtD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.00114	0.0078	CbGpPWpGaD
Hydroxychloroquine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00114	0.00146	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Dactinomycin—uterine cancer	0.00114	0.00145	CcSEcCtD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00113	0.00769	CbGpPWpGaD
Hydroxychloroquine—Pancytopenia—Epirubicin—uterine cancer	0.00113	0.00144	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events—HRAS—uterine cancer	0.00112	0.00766	CbGpPWpGaD
Hydroxychloroquine—Muscular weakness—Doxorubicin—uterine cancer	0.00112	0.00143	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—AKT1—uterine cancer	0.00111	0.0076	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—HRAS—uterine cancer	0.00111	0.00759	CbGpPWpGaD
Hydroxychloroquine—Eosinophilia—Doxorubicin—uterine cancer	0.00109	0.00139	CcSEcCtD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—HRAS—uterine cancer	0.00108	0.00739	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—HRAS—uterine cancer	0.00108	0.00739	CbGpPWpGaD
Hydroxychloroquine—Photosensitivity reaction—Epirubicin—uterine cancer	0.00108	0.00138	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—PIK3CA—uterine cancer	0.00108	0.00735	CbGpPWpGaD
Hydroxychloroquine—Weight decreased—Epirubicin—uterine cancer	0.00107	0.00137	CcSEcCtD
Hydroxychloroquine—Somnolence—Etoposide—uterine cancer	0.00107	0.00137	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CA—uterine cancer	0.00106	0.00726	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—KRAS—uterine cancer	0.00106	0.00722	CbGpPWpGaD
Hydroxychloroquine—Drowsiness—Epirubicin—uterine cancer	0.00106	0.00135	CcSEcCtD
Hydroxychloroquine—Vomiting—Dactinomycin—uterine cancer	0.00106	0.00135	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00105	0.00134	CcSEcCtD
Hydroxychloroquine—Rash—Dactinomycin—uterine cancer	0.00105	0.00134	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Etoposide—uterine cancer	0.00104	0.00134	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Doxorubicin—uterine cancer	0.00104	0.00133	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Etoposide—uterine cancer	0.00104	0.00133	CcSEcCtD
Hydroxychloroquine—Fatigue—Etoposide—uterine cancer	0.00104	0.00133	CcSEcCtD
Hydroxychloroquine—Pain—Etoposide—uterine cancer	0.00103	0.00132	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.001	0.00128	CcSEcCtD
Hydroxychloroquine—Weight decreased—Doxorubicin—uterine cancer	0.000992	0.00127	CcSEcCtD
Hydroxychloroquine—Nausea—Dactinomycin—uterine cancer	0.000987	0.00126	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Epirubicin—uterine cancer	0.000986	0.00126	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Etoposide—uterine cancer	0.000983	0.00126	CcSEcCtD
Hydroxychloroquine—Drowsiness—Doxorubicin—uterine cancer	0.000978	0.00125	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—PIK3CA—uterine cancer	0.000972	0.00664	CbGpPWpGaD
Hydroxychloroquine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000969	0.00124	CcSEcCtD
Hydroxychloroquine—Urticaria—Etoposide—uterine cancer	0.000955	0.00122	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Epirubicin—uterine cancer	0.000953	0.00122	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Etoposide—uterine cancer	0.00095	0.00122	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Etoposide—uterine cancer	0.00095	0.00122	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Epirubicin—uterine cancer	0.000948	0.00121	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000926	0.00632	CbGpPWpGaD
Hydroxychloroquine—Visual impairment—Epirubicin—uterine cancer	0.000914	0.00117	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Doxorubicin—uterine cancer	0.000912	0.00117	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—FGFR2—uterine cancer	0.000902	0.00616	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—HRAS—uterine cancer	0.0009	0.00614	CbGpPWpGaD
Hydroxychloroquine—Erythema multiforme—Epirubicin—uterine cancer	0.000897	0.00115	CcSEcCtD
Hydroxychloroquine—Eye disorder—Epirubicin—uterine cancer	0.000886	0.00113	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Etoposide—uterine cancer	0.000886	0.00113	CcSEcCtD
Hydroxychloroquine—Tinnitus—Epirubicin—uterine cancer	0.000884	0.00113	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Doxorubicin—uterine cancer	0.000882	0.00113	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—AKT1—uterine cancer	0.000881	0.00601	CbGpPWpGaD
Hydroxychloroquine—Haemorrhage—Doxorubicin—uterine cancer	0.000878	0.00112	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—AKR1B10—uterine cancer	0.000872	0.00595	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—uterine cancer	0.00087	0.00593	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Etoposide—uterine cancer	0.000862	0.0011	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IRF1—uterine cancer	0.00086	0.00587	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Etoposide—uterine cancer	0.00085	0.00109	CcSEcCtD
Hydroxychloroquine—Visual impairment—Doxorubicin—uterine cancer	0.000846	0.00108	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—PIK3CA—uterine cancer	0.000841	0.00574	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKR1B10—uterine cancer	0.000841	0.00574	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000841	0.00574	CbGpPWpGaD
Hydroxychloroquine—Alopecia—Epirubicin—uterine cancer	0.000838	0.00107	CcSEcCtD
Hydroxychloroquine—Mental disorder—Epirubicin—uterine cancer	0.000831	0.00106	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Doxorubicin—uterine cancer	0.00083	0.00106	CcSEcCtD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000829	0.00566	CbGpPWpGaD
Hydroxychloroquine—Malnutrition—Epirubicin—uterine cancer	0.000826	0.00106	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Etoposide—uterine cancer	0.000822	0.00105	CcSEcCtD
Hydroxychloroquine—Eye disorder—Doxorubicin—uterine cancer	0.00082	0.00105	CcSEcCtD
Hydroxychloroquine—Tinnitus—Doxorubicin—uterine cancer	0.000818	0.00105	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—AKR1B1—uterine cancer	0.000811	0.00553	CbGpPWpGaD
Hydroxychloroquine—Tension—Epirubicin—uterine cancer	0.00081	0.00104	CcSEcCtD
Hydroxychloroquine—Nervousness—Epirubicin—uterine cancer	0.000802	0.00103	CcSEcCtD
Hydroxychloroquine—Dizziness—Etoposide—uterine cancer	0.000795	0.00102	CcSEcCtD
Hydroxychloroquine—Vision blurred—Epirubicin—uterine cancer	0.000778	0.000996	CcSEcCtD
Hydroxychloroquine—Alopecia—Doxorubicin—uterine cancer	0.000775	0.000993	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—FBXW7—uterine cancer	0.00077	0.00526	CbGpPWpGaD
Hydroxychloroquine—Mental disorder—Doxorubicin—uterine cancer	0.000769	0.000984	CcSEcCtD
Hydroxychloroquine—Vomiting—Etoposide—uterine cancer	0.000764	0.000978	CcSEcCtD
Hydroxychloroquine—Malnutrition—Doxorubicin—uterine cancer	0.000764	0.000978	CcSEcCtD
Hydroxychloroquine—Anaemia—Epirubicin—uterine cancer	0.000763	0.000977	CcSEcCtD
Hydroxychloroquine—Agitation—Epirubicin—uterine cancer	0.000759	0.000971	CcSEcCtD
Hydroxychloroquine—Rash—Etoposide—uterine cancer	0.000758	0.00097	CcSEcCtD
Hydroxychloroquine—Dermatitis—Etoposide—uterine cancer	0.000757	0.000969	CcSEcCtD
Hydroxychloroquine—Headache—Etoposide—uterine cancer	0.000753	0.000964	CcSEcCtD
Hydroxychloroquine—Tension—Doxorubicin—uterine cancer	0.00075	0.000959	CcSEcCtD
Hydroxychloroquine—Nervousness—Doxorubicin—uterine cancer	0.000742	0.00095	CcSEcCtD
Hydroxychloroquine—Vertigo—Epirubicin—uterine cancer	0.000742	0.000949	CcSEcCtD
Hydroxychloroquine—Leukopenia—Epirubicin—uterine cancer	0.000739	0.000946	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Epirubicin—uterine cancer	0.000726	0.000929	CcSEcCtD
Hydroxychloroquine—Vision blurred—Doxorubicin—uterine cancer	0.00072	0.000921	CcSEcCtD
Hydroxychloroquine—Convulsion—Epirubicin—uterine cancer	0.000715	0.000916	CcSEcCtD
Hydroxychloroquine—Nausea—Etoposide—uterine cancer	0.000714	0.000914	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—FGFR2—uterine cancer	0.000713	0.00487	CbGpPWpGaD
Hydroxychloroquine—Anaemia—Doxorubicin—uterine cancer	0.000706	0.000904	CcSEcCtD
Hydroxychloroquine—Agitation—Doxorubicin—uterine cancer	0.000702	0.000899	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000698	0.000893	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—RNF43—uterine cancer	0.000697	0.00475	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—AKT1—uterine cancer	0.000687	0.00469	CbGpPWpGaD
Hydroxychloroquine—Vertigo—Doxorubicin—uterine cancer	0.000686	0.000878	CcSEcCtD
Hydroxychloroquine—Leukopenia—Doxorubicin—uterine cancer	0.000684	0.000875	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000681	0.00465	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IRF1—uterine cancer	0.000679	0.00464	CbGpPWpGaD
Hydroxychloroquine—Oedema—Epirubicin—uterine cancer	0.000674	0.000862	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Doxorubicin—uterine cancer	0.000671	0.000859	CcSEcCtD
Hydroxychloroquine—Convulsion—Doxorubicin—uterine cancer	0.000662	0.000847	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Epirubicin—uterine cancer	0.000661	0.000846	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Epirubicin—uterine cancer	0.00066	0.000844	CcSEcCtD
Hydroxychloroquine—Skin disorder—Epirubicin—uterine cancer	0.000655	0.000838	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000646	0.000827	CcSEcCtD
Hydroxychloroquine—Anorexia—Epirubicin—uterine cancer	0.000642	0.000822	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—INHBA—uterine cancer	0.000637	0.00435	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—SOCS3—uterine cancer	0.00063	0.0043	CbGpPWpGaD
Hydroxychloroquine—Oedema—Doxorubicin—uterine cancer	0.000623	0.000798	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Doxorubicin—uterine cancer	0.000611	0.000783	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Doxorubicin—uterine cancer	0.00061	0.000781	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—FBXW7—uterine cancer	0.000609	0.00415	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Doxorubicin—uterine cancer	0.000606	0.000775	CcSEcCtD
Hydroxychloroquine—Somnolence—Epirubicin—uterine cancer	0.000599	0.000767	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	0.000595	0.00406	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Doxorubicin—uterine cancer	0.000594	0.000761	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Epirubicin—uterine cancer	0.000586	0.00075	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000582	0.000745	CcSEcCtD
Hydroxychloroquine—Fatigue—Epirubicin—uterine cancer	0.000581	0.000744	CcSEcCtD
Hydroxychloroquine—Pain—Epirubicin—uterine cancer	0.000576	0.000738	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—AKR1C1—uterine cancer	0.000574	0.00391	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—ERBB2—uterine cancer	0.000567	0.00387	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Doxorubicin—uterine cancer	0.000554	0.000709	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000551	0.000705	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Doxorubicin—uterine cancer	0.000542	0.000694	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000538	0.000689	CcSEcCtD
Hydroxychloroquine—Fatigue—Doxorubicin—uterine cancer	0.000538	0.000688	CcSEcCtD
Hydroxychloroquine—Urticaria—Epirubicin—uterine cancer	0.000535	0.000685	CcSEcCtD
Hydroxychloroquine—Pain—Doxorubicin—uterine cancer	0.000533	0.000682	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Epirubicin—uterine cancer	0.000533	0.000682	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Epirubicin—uterine cancer	0.000533	0.000682	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—FGFR2—uterine cancer	0.000526	0.00359	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CDKN1B—uterine cancer	0.000525	0.00358	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	0.000523	0.00357	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00051	0.000653	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—SOCS3—uterine cancer	0.000498	0.0034	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Epirubicin—uterine cancer	0.000496	0.000635	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CTNNB1—uterine cancer	0.000496	0.00338	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Doxorubicin—uterine cancer	0.000495	0.000634	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Doxorubicin—uterine cancer	0.000493	0.000631	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Doxorubicin—uterine cancer	0.000493	0.000631	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	0.000492	0.00336	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	0.000485	0.00331	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Epirubicin—uterine cancer	0.000483	0.000619	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—PTEN—uterine cancer	0.000483	0.0033	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Epirubicin—uterine cancer	0.000477	0.00061	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Epirubicin—uterine cancer	0.000461	0.00059	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—EP300—uterine cancer	0.000461	0.00314	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Doxorubicin—uterine cancer	0.000459	0.000588	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	0.000458	0.00313	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—ERBB2—uterine cancer	0.000448	0.00306	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Doxorubicin—uterine cancer	0.000447	0.000573	CcSEcCtD
Hydroxychloroquine—Dizziness—Epirubicin—uterine cancer	0.000446	0.00057	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—AKR1C3—uterine cancer	0.000442	0.00301	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Doxorubicin—uterine cancer	0.000441	0.000565	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—NRAS—uterine cancer	0.000431	0.00294	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PGR—uterine cancer	0.00043	0.00294	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Epirubicin—uterine cancer	0.000428	0.000548	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Doxorubicin—uterine cancer	0.000427	0.000546	CcSEcCtD
Hydroxychloroquine—Rash—Epirubicin—uterine cancer	0.000425	0.000544	CcSEcCtD
Hydroxychloroquine—Dermatitis—Epirubicin—uterine cancer	0.000424	0.000543	CcSEcCtD
Hydroxychloroquine—Headache—Epirubicin—uterine cancer	0.000422	0.00054	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—FGFR2—uterine cancer	0.000415	0.00283	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CDKN1B—uterine cancer	0.000415	0.00283	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Doxorubicin—uterine cancer	0.000412	0.000528	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—YWHAE—uterine cancer	0.000411	0.0028	CbGpPWpGaD
Hydroxychloroquine—Nausea—Epirubicin—uterine cancer	0.0004	0.000512	CcSEcCtD
Hydroxychloroquine—Vomiting—Doxorubicin—uterine cancer	0.000396	0.000507	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—FBXW7—uterine cancer	0.000394	0.00269	CbGpPWpGaD
Hydroxychloroquine—Rash—Doxorubicin—uterine cancer	0.000393	0.000503	CcSEcCtD
Hydroxychloroquine—Dermatitis—Doxorubicin—uterine cancer	0.000393	0.000503	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CTNNB1—uterine cancer	0.000392	0.00267	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CDH1—uterine cancer	0.000391	0.00267	CbGpPWpGaD
Hydroxychloroquine—Headache—Doxorubicin—uterine cancer	0.000391	0.0005	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—PTEN—uterine cancer	0.000382	0.00261	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—KRAS—uterine cancer	0.000371	0.00253	CbGpPWpGaD
Hydroxychloroquine—Nausea—Doxorubicin—uterine cancer	0.00037	0.000474	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—EP300—uterine cancer	0.000364	0.00249	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	0.000362	0.00247	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	0.000357	0.00244	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—STK11—uterine cancer	0.000344	0.00235	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CA—uterine cancer	0.000341	0.00233	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—NRAS—uterine cancer	0.000341	0.00233	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ERBB2—uterine cancer	0.00033	0.00225	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SOCS3—uterine cancer	0.000322	0.0022	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—HRAS—uterine cancer	0.000315	0.00215	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDH1—uterine cancer	0.000309	0.00211	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN2B—uterine cancer	0.000308	0.0021	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CDKN1B—uterine cancer	0.000306	0.00209	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IGF1R—uterine cancer	0.0003	0.00204	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—KRAS—uterine cancer	0.000293	0.002	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CTNNB1—uterine cancer	0.000289	0.00197	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SMAD3—uterine cancer	0.000282	0.00192	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PTEN—uterine cancer	0.000281	0.00192	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—AKT1—uterine cancer	0.000278	0.0019	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CA—uterine cancer	0.000269	0.00184	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FGFR2—uterine cancer	0.000269	0.00183	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EP300—uterine cancer	0.000268	0.00183	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ERBB2—uterine cancer	0.000261	0.00178	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—NRAS—uterine cancer	0.000251	0.00171	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—HRAS—uterine cancer	0.000249	0.0017	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDKN1B—uterine cancer	0.000242	0.00165	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ESR1—uterine cancer	0.00023	0.00157	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CTNNB1—uterine cancer	0.000228	0.00156	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PTEN—uterine cancer	0.000222	0.00152	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—AKT1—uterine cancer	0.00022	0.0015	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—KRAS—uterine cancer	0.000216	0.00147	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EP300—uterine cancer	0.000212	0.00145	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCL2—uterine cancer	0.000202	0.00138	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CA—uterine cancer	0.000199	0.00135	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—NRAS—uterine cancer	0.000198	0.00135	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NDUFB11—uterine cancer	0.000194	0.00133	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SRD5A2—uterine cancer	0.000194	0.00133	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HRAS—uterine cancer	0.000184	0.00125	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KRAS—uterine cancer	0.000171	0.00117	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ERBB2—uterine cancer	0.000169	0.00115	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—AKT1—uterine cancer	0.000162	0.00111	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCL8—uterine cancer	0.00016	0.00109	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CA—uterine cancer	0.000157	0.00107	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN1B—uterine cancer	0.000156	0.00107	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CTNNB1—uterine cancer	0.000148	0.00101	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HRAS—uterine cancer	0.000145	0.000991	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTEN—uterine cancer	0.000144	0.000981	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—STAR—uterine cancer	0.000141	0.000959	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKR1B1—uterine cancer	0.000141	0.000959	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EP300—uterine cancer	0.000137	0.000936	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFA—uterine cancer	0.00013	0.000886	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NRAS—uterine cancer	0.000128	0.000876	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AKT1—uterine cancer	0.000128	0.000875	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KRAS—uterine cancer	0.00011	0.000754	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—POLD1—uterine cancer	0.00011	0.000753	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKR1C1—uterine cancer	0.000103	0.000704	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CA—uterine cancer	0.000101	0.000692	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TP53—uterine cancer	9.82e-05	0.00067	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HRAS—uterine cancer	9.39e-05	0.000641	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—RRM2—uterine cancer	9.2e-05	0.000628	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—DCN—uterine cancer	8.93e-05	0.000609	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP11A1—uterine cancer	8.41e-05	0.000574	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKT1—uterine cancer	8.29e-05	0.000566	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKR1C3—uterine cancer	7.95e-05	0.000542	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—STK11—uterine cancer	6.19e-05	0.000422	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP19A1—uterine cancer	6.19e-05	0.000422	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MTHFR—uterine cancer	4.65e-05	0.000317	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTEN—uterine cancer	2.59e-05	0.000177	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—EP300—uterine cancer	2.47e-05	0.000168	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.83e-05	0.000125	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKT1—uterine cancer	1.49e-05	0.000102	CbGpPWpGaD
